The agenda features a mix of clinical updates and lively debates on provocative scientific topics in the field.

November 1-2 | Nashville

Available DatesRegister

Friday November 01, 2024

  • 8:00 AM – 8:05 AM

    Welcome

    • Co-Chair
      • Erika HamiltonMD
  • 8:05 AM – 8:20 AM

    Debate: Advances in Early TNBC with Immunotherapy – Should We Continue Immunotherapy Post Surgery? - YES

    • Presenter
      • Tiffany TrainaMD, FASCO
  • 8:20 AM – 8:35 AM

    Debate: Advances in Early TNBC with Immunotherapy – Should We Continue Immunotherapy Post Surgery? - NO

    • Presenter
      • Melinda TelliMD
  • 8:35 AM – 8:45 AM

    Debate: Advances in Early TNBC with Immunotherapy – Should We Continue Immunotherapy Post Surgery? - DISCUSSION

    • Moderator
      • Erika HamiltonMD
    • Panelist
      • Melinda TelliMD
      • Tiffany TrainaMD, FASCO
  • 8:45 AM – 9:00 AM

    Debate: Antibody Drug Conjugates as the New Frontier: Should We Use Them Sequentially? - Yes, They Are Better than Chemo

    • Presenter
      • Kelly McCannMD, PhD
  • 9:00 AM – 9:15 AM

    Debate: Antibody Drug Conjugates as the New Frontier: Should We Use Them Sequentially? - No, the Benefit Is Really Just for the First ADC

    • Presenter
      • Denise YardleyMD
  • 9:15 AM – 9:25 AM

    Debate: Antibody Drug Conjugates as the New Frontier: Should We Use Them Sequentially? - DISCUSSION

    • Moderator
      • Erika HamiltonMD
    • Panelist
      • Kelly McCannMD, PhD
      • Denise YardleyMD
  • 9:25 AM – 9:35 AM

    Break

  • 9:35 AM – 10:35 AM

    Non-CME Innovation Theater - Sponsored by Pfizer

  • 10:35 AM – 11:15 AM

    Selected Topic in Breast Cancer